#01 Newsletter 27 de febrero 2021

Hello and welcome to the Stone News, a newsletter where we discuss every two months the most recent and relevant studies in stone disease.

Suscribe now

Themes introduction

In today’s newsletter we address three important issues in stone management. The first is the optimal treatment of lower pole stones of less than 2 cm, the gray area in which ESWL, RIRS, and PCNL can be an option.

The second topic is the relationship between tea and coffee consumption and the risk of urinary stones, with a focus on practical recommendations to help patients avoid stone formation and recurrences.

Finally, we will discuss the features of the new thulium fiber laser that was recently launched as a promising lithotripsy device.

I hope that this bulletin offers guidance that will assist in the better treatment of our patients.

img Systematic Review and Meta-Analysis Comparing Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery and Shock Wave Lithotripsy for Lower Pole Renal Stones Less Than 2 cm in Maximum Diameter img 2'
This systematic review and meta-analysis evaluated the three different treatment options for lower pole stones of less than 2 cm – ESWL, RIRS, and PCNL – with the objective of identifying which represents the most appropriate approach.
img Tea and coffee consumption and the risk of urinary stones – a systematic review of the epidemiological data img 2'
Patients very commonly ask endourologists about the nature of the relationship between the consumption of coffee and tea and stones, with the intention of avoiding urolithiasis precursors.
img The laser of the future: reality and expectations about the new thulium fiber laser-a systematic review img 2'
Holmium:YAG (Ho:YAG) laser is the most widely used laser in urology being the gold-standard for laser lithotripsy as it can treat all kinds of kidney stones. Recently the new thulium fiber laser (TFL) has been launched to compete with Ho:YAG.
facebook twiter youtube instagram
Aviso Legal | Política de privacidad
Este mail ha sido enviado a {{ contact.email }} por Devicare.
Si quiere darse de baja de las comunicaciones de la Stone News puede enviarnos un correo electrónico a
dpo@devicare.com o pinchar aquí.
Av. Can Domènech s/n | Eureka Building UAB Research Park | 08193 Cerdanyola del Vallès,
Barcelona | España
Copyright (c) 2021 Devicare.
logo Lit-Control